20:04 , Apr 25, 2019 |  BC Innovations  |  Finance

The academic founders' conundrum

First-time academic entrepreneurs face a circular problem: while they’re continually sought after by VCs and pharmas seeking the next “big thing”, they also face an arduous path to establish their bona fides - not for...
18:27 , Sep 7, 2018 |  BC Week In Review  |  Financial News

Exosome play Evox aims for clinic with £35.5M series B

Evox Therapeutics Ltd. (Oxford, U.K.) raised on Sept. 3 £35.5 million ($45.9 million) in a series B round led by Redmile Group. Also participating were GV, Cowen Healthcare Investments, Panacea Healthcare Venture, Borealis Ventures, Oxford...
23:30 , Sep 6, 2018 |  BioCentury  |  Finance

Evox populates its pipeline

As Evox Therapeutics Ltd. continues to refine the platform with which it develops exosome-based therapeutics, the company plans to use its £35.5 million ($45.9 million) series B round to start clinical trials on as many...
00:45 , Sep 4, 2018 |  BC Extra  |  Financial News

Exosome play Evox aims for clinic with £35.5M series B

Evox Therapeutics Ltd. (Oxford, U.K.) raised £35.5 million ($45.9 million) in a series B round led by Redmile Group. Also participating were GV, Cowen Healthcare Investments, Panacea Healthcare Venture, Borealis Ventures, Oxford Sciences Innovation (OSI),...
23:41 , Aug 3, 2018 |  BioCentury  |  Emerging Company Profile

Compass’ range

Compass Therapeutics LLC combines human cell display, high throughput antibody screening and a multispecific engineering platform to develop large libraries of cancer and autoimmune therapies. Traditional approaches to antibody discovery use hybridoma fusions in animals,...
18:54 , Jul 13, 2018 |  BC Week In Review  |  Financial News

With $132M series A, Compass points toward the clinic

Bispecific antibody play Compass Therapeutics LLC (Cambridge, Mass.) raised $49 million on July 12 in the final tranche of its series A round, bringing the round's total to $132 million. OrbiMed Advisers led the round....
15:35 , Jul 12, 2018 |  BC Extra  |  Financial News

With $132M series A, Compass points toward the clinic

Bispecific antibody play Compass Therapeutics LLC (Cambridge, Mass.) raised $49 million Thursday in the final tranche of its series A round, bringing the round's total to $132 million. OrbiMed Advisers led the round. F-Prime Capital...
07:00 , Aug 10, 2015 |  BC Week In Review  |  Financial News

Avitide completes venture financing

Avitide Inc. , Lebanon, N.H.   Business: Biomanufacturing   Date completed: 2015-08-06   Type: Venture financing   Raised: $7.6 million   Investors: NeoMed; Polaris Partners; OrbiMed Advisors; SV Life Sciences ; Borealis Ventures; N5 Investments;...
07:00 , Sep 30, 2013 |  BioCentury  |  Finance

Value ad(imab)

Adimab LLC 's VCs expect to be in the black starting next year thanks to the antibody company's three recent tech transfer deals, including one last week with Novo Nordisk A/S . Adimab hopes the...
07:00 , Mar 18, 2013 |  BC Week In Review  |  Company News

Avitide board of directors update

Avitide Inc. , Lebanon, N.H.   Business: Biomanufacturing   Appointed: Phil Ferneau, managing director at Borealis Ventures; and Michael Ross, managing director at SV Life Sciences  ...